Table 3.
Logistic regression model of medication adherence (PDC ≥80%) at 6 months following initiation of SPAA or CCB+statin
| 95% Confidence Limits | |||||
|---|---|---|---|---|---|
| Odds Ratio | Lower | Upper | Chi-Square | p-value | |
| Drug Group: SPAA vs. CCB+Statin | 4.70 | 4.22 | 5.23 | 793.06 | <.001 |
| Gender: Female vs. Male | 1.21 | 1.13 | 1.30 | 30.59 | <.001 |
| Pre-index Comorbidity of: | |||||
| Diabetes Mellitus | 1.00 | 0.92 | 1.07 | 0.02 | 0.891 |
| Dyslipidemia | 1.22 | 1.14 | 1.32 | 27.80 | <.001 |
| Obesity | 0.84 | 0.72 | 0.98 | 5.15 | 0.023 |
| Peripheral Vascular Disease | 0.75 | 0.59 | 0.94 | 6.26 | 0.012 |
| Chronic Obstructive Pulmonary Disease | 0.82 | 0.67 | 0.99 | 4.17 | 0.041 |
| Number of Pre-Index Other Antihypertensive Classes | 1.12 | 1.06 | 1.18 | 18.93 | <.001 |